MBP_RCT: Module-Based Psychological (MBP) RCT for Community Youths

Sponsor
The University of Hong Kong (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06005961
Collaborator
The Hong Kong Jockey Club Charities Trust (Other)
400
2
20.2

Study Details

Study Description

Brief Summary

This waitlist, randomised controlled trial (RCT) aims to examine the effectiveness of the Module-Based Psychological (MBP) intervention in reducing mental distress for youths aged 12-30 years in Hong Kong. The participants randomised to the MBP group will receive 5 weekly sessions of MBP in an individual format delivered by frontline social or youth workers trained by professional clinicians. The waitlist control group will receive the same intervention after 5 weeks of waiting plus a 1-month follow-up period. The MBP is designed to improve the youths' abilities/skills in handling moods for better emotional management. Written informed consent will be signed by participants or their parents/guardians if they are under the age of 18.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Module-Based Psychological (MBP) Intervention
N/A

Detailed Description

This randomised controlled trial (RCT) aims to examine the effectiveness of the Module-Based Psychological (MBP) intervention in reducing mental distress for youths in Hong Kong. This intervention study will be delivered in an individual format for 5 weeks by frontline social or youth workers trained by professional clinicians. It is designed to improve the youths' abilities and skills in handling moods for better emotional management. The MBP intervention has two modules: core and tailor-made modules. The core module focuses on emotional management, while the five tailor-made modules include anxiety management, mood and depression management, anger management, sleeping well, and managing self-expectation and compassion. The tailor-made modules will be assigned to youths according to their needs. While the clinical outcome of the MBP is evaluated, its cost-effectiveness is also of particular concern. Planned interim analyses are built into the project for the sake of evaluation of the collected data from the ongoing trial, in which the primary research question is addressed and which has the potential to modify the conduct of the study. It is hypothesised that the youths who have received MBP intervention will demonstrate a greater reduction in mental distress, depressive symptoms, and anxiety symptoms compared to the youths in the waitlist control group. Besides, the MBP intervention will be more cost-effective than waiting.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Randomised Controlled Trial of Module-Based Psychological (MBP) Intervention for Young People With Mental Distress in Hong Kong
Anticipated Study Start Date :
Aug 25, 2023
Anticipated Primary Completion Date :
Jan 1, 2025
Anticipated Study Completion Date :
May 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: MBP intervention arm

The MBP intervention has two modules: the core and the tailor-made modules. The core module focuses on emotional management, while the five tailor-made modules include anxiety management, mood and depression management, anger management, sleeping well, and managing self-expectation and compassion.

Behavioral: Module-Based Psychological (MBP) Intervention
Participants will receive one core module related to emotional management and maximum two tailor-made modules according to the participant's needs. Each weekly session lasts for 1 hours. The core module will last for 5 weeks and the tailor-made modules will last for 3 - 4 weeks.

Other: Waitlist control arm

Participants allocated to the waitlist control group will wait for 5 plus 4 weeks before receiving the MBP intervention.

Behavioral: Module-Based Psychological (MBP) Intervention
Participants will receive one core module related to emotional management and maximum two tailor-made modules according to the participant's needs. Each weekly session lasts for 1 hours. The core module will last for 5 weeks and the tailor-made modules will last for 3 - 4 weeks.

Outcome Measures

Primary Outcome Measures

  1. General mental distress [baseline (T0), post-treatment (5-week, T1), and follow-up (9 week, T2)]

    Measured using the Kessler Psychological Distress Scale, 6-item version (K6). The total K6 score ranges from 0 to 24, with higher scores indicating a greater distress level.

  2. Depressive symptoms [baseline (T0), post-treatment (5-week, T1), and follow-up (9 week, T2)]

    Measured using the 7-item Depression Subscale of the Depression, Anxiety, and Stress Scale, 21-item version (DASS-D). The total score ranges from 0-42, with higher scores indicating greater severity of depressive symptoms.

  3. Anxiety symptoms [baseline (T0), post-treatment (5-week, T1), and follow-up (9 week, T2)]

    Measured using the 7-item Anxiety Subscale of the Depression Anxiety and Stress Scale 21-item version (DASS-A) The total score ranges from 0-42, with higher scores indicating greater severity of anxiety symptoms.

  4. Functioning [baseline (T0), post-treatment (5-week, T1), and follow-up (9 week, T2)]

    Measured using the Social and Occupational Functioning Assessment Scale (SOFAS). The score ranges from 0-100, with higher scores indicating better social and occupational functioning related to physical and mental health.

Secondary Outcome Measures

  1. Health-related quality of life [baseline (T0), post-treatment (5-week, T1), and follow-up (9 week, T2)]

    Measured using the 12-Item Short Form Health Survey (SF-12). The derived index score ranges from 0-100, with higher scores indicating better physical and mental health functioning.

  2. Self-compassion [baseline (T0), post-treatment (5-week, T1), and follow-up (9 week, T2)]

    Measured using the 12-item Self-Compassion Scale (SCS). The total score ranges from 5-60, with higher scores indicating better self-compassion.

  3. Self-efficacy [baseline (T0), post-treatment (5-week, T1), and follow-up (9 week, T2)]

    Measured using the 10-item General Self-Efficacy Scale (GSE). The total score ranges from 10 and 40, with higher scores indicating more self-efficacy.

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. LevelMind@JC users aged from 12-30

  2. Reported at-least mild mental distress

  3. Have sufficient proficiency in Chinese to understand verbal instructions

  4. Able to give informed consent

Exclusion Criteria:
  1. Known diagnosis of intellectual disability

  2. Known diagnosis of organic brain disorder

  3. Known psychiatric diagnosis

  4. Current substance abuse

  5. Receiving any psychiatric treatments or structural psychological therapies such as cognitive behavioural therapy, mentalisation-based therapy and low-intensity online intervention, narrative therapy, mindfulness, and art-informed therapy

  6. Current or active suicidal ideation or attempts

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • The University of Hong Kong
  • The Hong Kong Jockey Club Charities Trust

Investigators

  • Principal Investigator: Christy Lai-ming Hui, The University of Hong Kong

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Christy Lai-ming Hui, Associate professor, The University of Hong Kong
ClinicalTrials.gov Identifier:
NCT06005961
Other Study ID Numbers:
  • MBP_intervention
First Posted:
Aug 23, 2023
Last Update Posted:
Aug 23, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. Christy Lai-ming Hui, Associate professor, The University of Hong Kong
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 23, 2023